INTRODUCTION
============

Depression is a mood disorder frequently causing impairment in many areas of functioning, and has a relatively high prevalence ranging from 2% to 15% \[[@b1-pi-2017-09-11]\]. The medical and economic burden of depression is considerable because major depression is a leading cause of morbidity, mortality, and disability \[[@b2-pi-2017-09-11]\]. People with depression often suffer from comorbid chronic physical conditions such as hypertension \[[@b3-pi-2017-09-11]\], stroke \[[@b4-pi-2017-09-11]\], asthma \[[@b5-pi-2017-09-11]\], and arthritis \[[@b6-pi-2017-09-11]\]. Depression is known to increase the risk for chronic diseases, and may worsen the course of these diseases \[[@b7-pi-2017-09-11],[@b8-pi-2017-09-11]\]. Possible reasons for such high comorbidity among the patients with depression include unhealthy lifestyle related to the depressive state such as smoking, poor adherence to medical regimens, and biological impact of depression on proinflammatory factors, the hypothalamic-pituitary axis, autonomic nervous system, and metabolic factors \[[@b7-pi-2017-09-11],[@b9-pi-2017-09-11],[@b10-pi-2017-09-11]\].

The relationship between depression and chronic physical diseases can further be associated with other factors such as age and sex. Previous studies have reported that the impact of depression on health conditions such as chronic medical disorders and health-related quality of life is unequally distributed among different population groups of age, sex, marital status, economy, and employment \[[@b2-pi-2017-09-11],[@b11-pi-2017-09-11]\]. Despite these differences in the association between depression and health outcomes across the demographic groups, little is known about the prevalence of chronic physical diseases comorbid with depression among the different demographic groups. Therefore, this study aimed to estimate the prevalence of diverse, comorbid, chronic physical diseases across sex and age groups using a Korean representative nationwide sample.

METHODS
=======

Study sample and measures
-------------------------

This study used the Korean National Health and Nutrition Examination Survey (KNHANES). The KNHANES included cross-sectional health interview survey, health examination survey, and nutrition survey conducted with a representative sample of non-institutionalized Korean civilian population \[[@b12-pi-2017-09-11]\]. The Institutional Review Board of Korea Centers for Disease Control and Prevention approved the protocol (2007-02CON-04-P, 2008-04EXP-01-C, 2009-01CON-03-2C, 2010-02CON-21-C, 2011-02CON-06-C, 2012-01EXP-01-2C, 2013-07CON-03-4C, and 2013-12EXP-03-5C). We included the data of 45,598 respondents who participated in both the health interviews and examinations of a total of 50,094 respondents aged 19 years or older, between 2007 and 2014.

Data about depression, arthritis, angina or myocardial infarction, stroke, tuberculosis, asthma, chronic renal failure, atopic dermatitis, thyroid gland disease, cancer (stomach, liver, colorectal, and breast) and cirrhosis of the liver were collected using questions about being diagnosed; for example, "Have you ever been diagnosed with depression by a physician?" \[[@b12-pi-2017-09-11]\].

Metabolic syndrome was measured in the health examination. These health examinations were conducted in local community health centers and clinics, and standardized protocols were used to assess anthropometry, blood pressure, and laboratory indices. Metabolic syndrome was considered to be present if at least 3 of the following 5 criteria were satisfied: 1) abdominal obesity (waist circumference of ≥85 cm), measured using a Korean-specific standard; 2) high blood pressure (SBP of ≥130 mm Hg or DBP of ≥85 mm Hg); 3) a high TG level (≥150 mg/dL); 4) a low HDL-C level (\<50 mg/dL); and 5) elevated FPG (≥100 mg/dL). We used the version of the National Cholesterol Education Program's Adult Treatment Panel III criteria recommended by the American Heart Association and the National Heart, Lung, and Blood Institute \[[@b12-pi-2017-09-11]\].

We defined adults as respondents aged 19--64 years, and elderly as respondents aged 65 years and above.

Statistical analysis
--------------------

The age-standardized prevalence rates for comorbidity of depression with chronic physical diseases were estimated using the standard population from the Population Projections for Korea: 2010--2016 (based on the 2010 census). Log-binomial regression was performed to estimate age adjusted prevalence ratios (APRs) of chronic physical diseases for respondents with depression and those without depression. We used SAS software version 9.4 (SAS institute Inc., Cary, NC, USA) for all analyses.

RESULTS
=======

Of the total population (n=45,598), 3.7% (n=1,860) had been diagnosed with depression by physicians. Of the adults aged 19--64 years (n=34,837), 3.4% (n=1,289) and 5.1% (n=571) of the elderly aged 65 years and above (n=10,761) were diagnosed with depression. Of male respondents (n=19,263), 1.8% (n=355) and 5.4% (n=1,505) of female respondents (n=26,335) reported that they had depression ([Table 1](#t1-pi-2017-09-11){ref-type="table"}).

As shown in [Tables 2](#t2-pi-2017-09-11){ref-type="table"} and [3](#t3-pi-2017-09-11){ref-type="table"}, age-standardized prevalence rates for metabolic syndrome were high among respondents with depression in all sex and age-groups. In addition to the aforementioned diseases, asthma in adult male respondents (7.53%, SE=2.13%), thyroid gland disease in adult female respondents (6.92%, SE=0.89%), tuberculosis in elderly male respondents (5.35%, SE=1.52%), and asthma in elderly female respondents (4.19%, SE=0.78%) showed high prevalence rates among respondents with depression.

The APR of most chronic physical diseases were significantly higher among respondents with depression than those without depression. We specifically focused on the chronic physical diseases that were highly associated with depression (with APR higher than 2). Arthritis showed the highest APR of 2.41 (95% CI=2.27--2.40) in the adult male group, followed by the elderly male group (APR=2.06, 95% CI=2.03--2.09). The APR of arthritis was higher in adult respondents than elderly respondents and in men than women. Similarly, asthma showed the highest APR of 3.46 (95% CI=3.42--3.51) in the adult male group, followed by the elderly male group (APR=2.33, 95% CI=2.27--2.40). Like arthritis, APR of this disease was higher in adult respondents than elderly respondents and in men than women. The APR of chronic renal failure was remarkably higher in elderly male group than other groups. There was a difference in the APR of chronic renal failure between the elderly group and adult group among men (APR=8.36, 95% CI=8.01--8.72 vs. APR=1.57, 95% CI=1.49--1.66), but not among women (APR=1.94, 95% CI=1.87--2.02 vs. APR=2.05, 95% CI=1.99--2.10). Thyroid gland disease also showed higher APR in elderly male group than other groups. There was a difference in the APR of thyroid gland disease between the elderly group and adult group among men (APR=3.60, 95% CI=3.44--3.77 vs. APR=1.45, 95% CI=1.40--1.50), but not among women (APR=1.22, 95% CI=1.20--1.24 vs. APR=1.44, 95% CI=1.43--1.46). Cirrhosis of the liver also showed higher APR in the elderly male group than other groups. There was a difference in the APR of cirrhosis of the liver between the elderly group and adult group among both men (APR=2.27, 95% CI=2.13--2.42 vs. APR=1.69, 95% CI=1.60--1.78) and women (APR=1.36, 95% CI=1.28--1.45 vs. APR=0.53, 95% CI=0.49--0.58) Stroke (APR=1.79, 95% CI=1.75--1.82) and cancer (APR=1.66, 95% CI=1.64--1.69) had higher APRs in the adult female group than other groups ([Table 2](#t2-pi-2017-09-11){ref-type="table"} and [3](#t3-pi-2017-09-11){ref-type="table"}).

Among the respondents with depression, though prevalence rates of chronic renal failure were lower than other physical diseases, APRs of this disease were fairly high, compared to those without depression, showing a maximum of 8-fold increase in elderly male respondents with depression compared to those without depression. On the contrary, the prevalence rates of metabolic syndrome were very high, but APRs of this disease was relatively low in respondents with depression because of its high prevalence among both, respondents with and those without depression ([Table 2](#t2-pi-2017-09-11){ref-type="table"} and [3](#t3-pi-2017-09-11){ref-type="table"}).

DISCUSSION
==========

To our knowledge, this study is the first to present APRs of diverse, chronic physical diseases related to depression among sex and age groups separately. Our results have shown that the prevalence of most chronic physical diseases are significantly higher among respondents with depression than those without depression and associations between depression and chronic physical diseases is unequally distributed across sex and agegroups.

The noticeable result was that elderly male respondents with depression were much more vulnerable to chronic physical diseases (i.e., arthritis, angina, asthma, renal failure, thyroid gland disease, and cirrhosis of the liver) than elderly female respondents with depression, although the prevalence of depression in elderly female respondents was about three times higher than in elderly male respondents (6.9% and 2.4% respectively). There were more chronic physical diseases that showed an APR higher than 2 in elderly male respondents than any other groups. Such diseases include arthritis, asthma, chronic renal failure, thyroid gland disease, and cirrhosis (APRs of 2.06, 2.33, 8.36, 3.60, and 2.27, respectively). Our finding is consistent with the results of a Korean study which found that the association between depressive symptoms and a number of physical illnesses is stronger in older male respondents than older female respondents and having one or more physical illnesses increased the risk of suicidal ideation in older male respondents, but not in older female respondents \[[@b13-pi-2017-09-11]\].

Such a high comorbidity of depression with physical diseases among older male respondents may be partially explained by the vulnerability of older men in a post-retirement environment and widowhood. Isolation and loneliness related to changes in role identity after retirement or loss of a partner or a relationship was found to be more detrimental for elderly male subjects than elderly female subjects \[[@b14-pi-2017-09-11]\]. Alpass and Neville \[[@b15-pi-2017-09-11]\] suggested that loneliness in older men negatively affects relationships and independent functioning and may eventually lead to depression. Such detrimental effects of loneliness and impoverished relationships in older men could affect their regular functioning in terms of eating a healthy diet and taking medication, which can also adversely affect their physical health \[[@b16-pi-2017-09-11]\]. On the contrary, disability due to physical illness may increase the risk of loneliness or depression \[[@b7-pi-2017-09-11],[@b17-pi-2017-09-11]\]. The links between loneliness, depression, and physical illness are complex, so the causal mechanisms have been difficult to demonstrate \[[@b18-pi-2017-09-11]\].

Especially, chronic renal failure has shown the highest APR (APR=8.36, 95% CI=8.01--8.72) in elderly male respondents with depression among all sex and age groups in our findings. Little is known about why chronic renal failure is disproportionately common in elderly men with depression compared to those without depression. However, the facts that the annual incidence of chronic renal failure increases rapidly with advancing age, and is three times higher in male patients than female patients who are 75 years old or more \[[@b19-pi-2017-09-11]\] and that deterioration of renal function in patients with chronic renal disease is more rapid in male patients than in female patients \[[@b20-pi-2017-09-11]\] might be related to the high comorbidity of chronic renal failure in elderly men with depression. Most studies reported the development of depression among patients with chronic renal diseases \[[@b21-pi-2017-09-11]\]. However, a recent review showed the bidirectional and multifactorial relationship between kidney disease and depression \[[@b22-pi-2017-09-11]\]. Bautovich et al. have suggested that depression can increase the risk of chronic kidney disease as it has biological consequences, such as increased inflammation, and negative self-care behaviors, such as sedentary lifestyles and poor compliance with medical care. Furthermore, such comorbidity of depression with chronic renal disease is highly associated with an increased risk of adverse outcomes such as hospitalization, death, suicide \[[@b23-pi-2017-09-11]-[@b25-pi-2017-09-11]\] and hence careful treatment and follow-up are required.

Previous studies have reported the comorbidity between depression and arthritis, especially rheumatoid arthritis. In a cross-sectional study, almost three-fourths (71.5%) of rheumatoid arthritis patients were found to have depression, and the level of depression was strongly associated with rheumatoid arthritis disease activity \[[@b6-pi-2017-09-11]\]. A longitudinal study in Taiwan investigated the strong bidirectional association between depression and rheumatoid arthritis, and found hazard ratios of 1.69 (95% CI=1.51--1.87) of depression in rheumatoid arthritis and hazard ratios of 1.65 (95% CI=1.41--1.77) of rheumatoid arthritis in depression \[[@b26-pi-2017-09-11]\]. This study reported that neurotransmitter deregulation and dysfunctional intracellular signaling are possible mechanisms linking psychological stress with immune-related diseases \[[@b26-pi-2017-09-11]\]. In the present study, interestingly, although the prevalence rate of depression comorbid with arthritis was about two times higher in female respondents than male respondents in both adult and elderly groups, the APR of arthritis was higher in male respondents with depression than female respondents with depression. Additionally, adult respondents with depression had higher APR of arthritis than elderly respondents with depression. Consistent with our findings, a review of comorbidities with rheumatoid arthritis reported that there are sex-specific differences in the prevalence of comorbidities of arthritis and depression, and thus, suggested that sex-specific aspects should be taken in to consideration in the treatment of these comorbidities \[[@b27-pi-2017-09-11]\]. In our study, respondents with depression in all sex and age groups were twice as likely to have asthma than those without depression with the exception of the elderly female group, with the highest APR of asthma occurring among adult male respondents with depression. The APR of asthma was higher in respondents with depression among adult groups than elderly groups. Consistent with our findings, a cohort study reported that incidence of asthma was 1.91 times higher in patients with depression than in those without depression, and younger patients aged 20--49 years had a higher hazard ratio of asthma than the older patients aged 65 years or more \[[@b28-pi-2017-09-11]\]. A recent meta-analysis that involved eight cohorts reported that depression was associated with a 43% increased risk of developing asthma \[[@b29-pi-2017-09-11]\]. It is reported that depressing stimuli may cause airway instability and can lead to asthma \[[@b30-pi-2017-09-11]\]. Van Lieshout et al. \[[@b5-pi-2017-09-11]\] further suggested that malfunctioning of the hypothalamic pituitary adrenal axis may predispose people to both depression and asthma and bring about similar changes in the immune, autonomic nervous, and other important systems which may also contribute to the comorbidity of depression with asthma.

There were several limitations that should be considered when interpreting the results. First, the cross-sectional design of this study did not allow the investigation of the temporal or causal relationship between depression and a chronic physical disease. The association between depression and chronic physical diseases is increasingly considered to be bidirectional \[[@b7-pi-2017-09-11]\]. Second, the diagnosis of depression was made based on self-reported diagnosis using a single question, rather than a structured diagnostic interview or a standardized assessment tool; therefore, there may be some cases of misclassification of depression, although self-reported diagnosis is reported to be largely congruent with clinical record data \[[@b31-pi-2017-09-11]\]. Future studies using standardized assessment or medical examination are needed to confirm our findings.

Despite these limitations, the strength of our study was that we used a large, nationally representative sample, and showed the differences in the prevalence of diverse, chronic physical diseases comorbid with depression across sex and age groups, which, to our knowledge, had not been established through previous studies. Our findings suggested that the prevalence of chronic physical diseases that are more likely to occur in patients with depression was different in different groups in the population. For example, older male respondents with depression showed a much higher risk of having chronic renal failure than the other groups. Thus, professionals in the fields of mental and physical health should realize the seriousness of physical diseases comorbid with depression, and collaborative care strategies should be designed according to demographic characteristics of the population. Future studies will be needed to further explore the depth of depression's effect on a chronic disease according to the characteristics of the population.
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###### 

Demographic characteristics of the samples according to presence of lifetime depression diagnosis among Koreans (aged 19 years or over)

                                                                           Total           Depression (N=1,860)   Non-depression (N=14,504)   p-value^[\*](#tfn1-pi-2017-09-11){ref-type="table-fn"}^
  ------------------------------------------------------------------------ --------------- ---------------------- --------------------------- ---------------------------------------------------------
  Age groups, year, N (%)^[†](#tfn2-pi-2017-09-11){ref-type="table-fn"}^                                                                      \<0.0001
   19--64                                                                  34,837 (85.8)   1,289 (3.4)            33,548 (96.6)               
   ≥65                                                                     10,761 (14.2)   571 (5.1)              10,190 (94.9)               
  Sex, N (%)^[†](#tfn2-pi-2017-09-11){ref-type="table-fn"}^                                                                                   \<0.0001
   Male                                                                    19,263 (49.2)   355 (1.8)              18,908 (98.2)               
   Female                                                                  26,335 (50.8)   1,505 (5.4)            24,830 (94.6)               
  Education, N (%)^[†](#tfn2-pi-2017-09-11){ref-type="table-fn"}^                                                                             \<0.0001
   ≥High school                                                            28,364 (71.2)   832 (2.8)              27,532 (97.2)               
   \<High school                                                           17,088 (28.8)   1,019 (5.8)            16,069 (94.2)               
  Arthritis                                                                6,180 (9.7)     535 (22.8)             5,645 (9.2)                 \<0.0001
  Angina or myocardial infarction                                          1,132 (1.8)     87 (3.1)               1,045 (1.7)                 \<0.0001
  Stroke                                                                   1,001 (1.5)     76 (2.7)               925 (1.5)                   \<0.0001
  Tuberculosis                                                             2,255 (4.4)     116 (5.4)              2,139 (4.4)                 \<0.0001
  Asthma                                                                   1,480 (2.9)     133 (7.0)              1,347 (2.8)                 \<0.0001
  Chronic renal failure                                                    196 (0.4)       22 (0.9)               174 (0.3)                   \<0.0001
  Atopic dermatitis                                                        1,112 (2.9)     55 (2.9)               1,057 (2.9)                 0.9983
  Thyroid gland disease                                                    1,655 (3.0)     140 (6.2)              1,515 (2.8)                 \<0.0001
  Cancer^[‡](#tfn3-pi-2017-09-11){ref-type="table-fn"}^                    740 (1.2)       47 (2.3)               693 (1.2)                   0.0015
  Cirrhosis of the liver                                                   120 (0.2)       8 (0.3)                112 (0.2)                   0.4688
  Metabolic syndrome                                                       13,965 (28.5)   615 (30.9)             13,350 (28.4)               0.0644

statistical significance of difference between groups with and without depression,

\% population weighted proportions,

any cancer including stomach, liver, colorectal, and breast cancers

###### 

Age-standardized prevalence of chronic physical diseases according to presence of lifetime depression diagnosis among Korean males

                                                           Adult male (aged 19--64 years)   Elderly male (aged 65 years or older)                                                     
  -------------------------------------------------------- -------------------------------- --------------------------------------- ------------------- -------------- -------------- -------------------
  Arthritis                                                7.02 (1.84)                      2.86 (0.15)                             2.41 (2.38--2.44)   10.72 (1.89)   5.47 (0.25)    2.06 (2.03--2.09)
  Angina or myocardial infarction                          1.71 (0.68)                      1.26 (0.10)                             1.26 (1.22--1.29)   4.99 (1.35)    2.90 (0.19)    1.89 (1.85--1.93)
  Stroke                                                   1.87 (0.72)                      1.02 (0.10)                             1.60 (1.56--1.64)   4.22 (1.25)    2.82 (0.18)    1.37 (1.34--1.41)
  Tuberculosis                                             4.70 (1.32)                      4.44 (0.18)                             1.01 (0.99--1.03)   5.35 (1.52)    4.69 (0.24)    1.22 (1.19--1.24)
  Asthma                                                   7.53 (2.13)                      1.99 (0.13)                             3.46 (3.42--3.51)   3.83 (1.42)    1.64 (0.14)    2.33 (2.27--2.40)
  Chronic renal failure                                    0.52 (0.50)                      0.25 (0.04)                             1.57 (1.49--1.66)   1.83 (0.82)    0.24 (0.05)    8.36 (8.01--8.72)
  Atopic dermatitis                                        3.31 (1.21)                      2.72 (0.16)                             1.31 (1.28--1.33)   0.40 (0.30)    0.49 (0.08)    1.04 (0.96--1.12)
  Thyroid gland disease                                    0.88 (0.45)                      0.73 (0.07)                             1.45 (1.40--1.50)   1.30 (0.59)    0.45 (0.07)    3.60 (3.44--3.77)
  Cancer^[\*](#tfn4-pi-2017-09-11){ref-type="table-fn"}^   1.33 (0.75)                      0.72 (0.07)                             1.54 (1.49--1.59)   2.33 (1.19)    1.90 (0.16)    1.22 (1.18--1.26)
  Cirrhosis of the liver                                   0.54 (0.39)                      0.21 (0.04)                             1.69 (1.60--1.78)   0.59 (0.41)    0.35 (0.07)    2.27 (2.13--2.42)
  Metabolic syndrome                                       40.93 (3.58)                     34.47 (0.44)                            1.13 (1.13--1.14)   18.91 (2.25)   19.13 (0.39)   1.02 (1.01--1.03)

any cancer including stomach, liver, colorectal, and breast cancers.

APR: age-adjusted prevalence ratio

###### 

Age-standardized prevalence of chronic physical diseases according to presence of lifetime depression diagnosis among Korean females

  Chronic physical diseases                                Adult female (aged 19--64 years)   Elderly female (aged 65 years or older)                                                     
  -------------------------------------------------------- ---------------------------------- ----------------------------------------- ------------------- -------------- -------------- -------------------
  Arthritis                                                15.26 (1.10)                       8.86 (0.22)                               1.65 (1.64--1.65)   21.02 (1.21)   18.04 (0.35)   1.16 (1.15--1.16)
  Angina or myocardial infarction                          0.95 (0.22)                        0.90 (0.08)                               1.12 (1.10--1.14)   3.54 (0.61)    2.19 (0.15)    1.74 (1.72--1.76)
  Stroke                                                   1.16 (0.31)                        0.59 (0.06)                               1.79 (1.75--1.82)   3.01 (0.55)    1.99 (0.16)    1.41 (1.39--1.43)
  Tuberculosis                                             3.85 (0.62)                        2.93 (0.14)                               1.29 (1.28--1.31)   2.68 (0.52)    1.68 (0.13)    1.58 (1.55--1.60)
  Asthma                                                   5.13 (0.78)                        2.31 (0.12)                               2.19 (2.17--2.21)   4.19 (0.78)    2.58 (0.17)    1.55 (1.53--1.57)
  Chronic renal failure                                    0.57 (0.24)                        0.31 (0.05)                               2.05 (1.99--2.10)   0.63 (0.24)    0.31 (0.05)    1.94 (1.87--2.02)
  Atopic dermatitis                                        3.01 (0.61)                        2.96 (0.15)                               1.12 (1.10--1.13)   0.57 (0.23)    0.36 (0.06)    1.56 (1.51--1.62)
  Thyroid gland disease                                    6.92 (0.89)                        4.42 (0.16)                               1.44 (1.43--1.46)   2.82 (0.54)    2.35 (0.16)    1.22 (1.20--1.24)
  Cancer^[\*](#tfn5-pi-2017-09-11){ref-type="table-fn"}^   1.30 (0.36)                        0.85 (0.07)                               1.66 (1.64--1.69)   1.74 (0.59)    1.29 (0.12)    1.24 (1.21--1.27)
  Cirrhosis of the liver                                   0.07 (0.05)                        0.10 (0.02)                               0.53 (0.49--0.58)   0.17 (0.12)    0.16 (0.05)    1.36 (1.28--1.45)
  Metabolic syndrome                                       17.59 (1.27)                       13.53 (0.28)                              1.19 (1.18--1.19)   17.97 (1.22)   18.06 (0.37)   0.99 (0.98--1.00)

any cancer including stomach, liver, colorectal, and breast cancers.

APR: age-adjusted prevalence ratio
